News
College of Optometrists welcomes over 500 new optometrists to the profession at the 2024 Diploma Ceremonies
Last week, the College of Optometrists welcomed over 500 new optometrists to the profession in two College Diploma Ceremonies in Westminster on 12 November 2024, where new members were joined by their family, friends and peers. The ceremonies took place...
Research into headlight glare commissioned by government
The government has commissioned much needed research into the causes of night-time headlight glare, after campaigning involving the College of Optometrists among others. The College spearheaded the lobbying on behalf of the optical sector, in collaboration with colleagues from the...
The Worshipful Company of Spectacle Makers rewards early career research
The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of its annual bronze medal award competitions for vision research. Both the winning submissions demonstrated models for earlier diagnosis of significant eye disease and have the capacity to...
Vision for the future: Changes to Glaucoma UK’s research programme in 2025
Glaucoma UK is excited to announce a new, reshaped Research Grants Programme for 2025. Set to open in January, this programme aims to support innovative research to improve the understanding, treatment, and care of glaucoma. Alongside opportunities for researchers at...
Glaucoma UK and the Royal College of Ophthalmologists announce the 2024 research award winners
Glaucoma UK and the Royal College of Ophthalmologists are delighted to announce the winners of the 2024 Glaucoma UK/RCOphth Research Award. As a result of the high quality of applications received, the judging panel have awarded two projects, worth nearly...
ABDO announces groundbreaking therapy for contact lens opticians
The Association of British Dispensing Opticians (ABDO) has given the go ahead for contact lens opticians to prescribe a groundbreaking new therapy, enabling ~1,700 new practitioners to offer the treatment to their patients. NuVision Biotherapies, a UK based tissue-therapy company...
HOYA Vision Care’s Defocus Incorporated Multiple Segments Spectacle Lenses demonstrated significant trend of myopia control in children
Interim analysis from the Observational French Study in children presented at EPOS 2024 meeting in Paris. Data from an interim analysis of the Observational French Study, OPHTAMYOP, has demonstrated a significant trend of myopia control in children with spherical equivalent...
New study uncovers key mechanism behind a common genetic cause of age-related visual loss
A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...
MicroPulse Transscleral Laser Therapy: A Prospective UK Study
Register now to participate. Eagerly anticipated and now underway – a landmark UK medical research study on MicroPulse® Transscleral Laser Therapy (MPTLT) for the treatment of glaucoma using Iridex’ Cyclo G6® Laser and the MicroPulse P3® Delivery Device. A NICE-compliant...
Biomarkers reveal how patients with glaucoma may respond to treatment
Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers at UCL and Moorfields Eye Hospital.
Boosting key protein in eye cells could prevent age-related vision loss, international team finds
Increasing the levels of a key protein in the cells at the back of the eye could help protect against the leading cause of vision loss among older adults, finds a new discovery made by researchers from the UK, US, Germany and Australia.
New study maps priorities for UK eyecare research
Glaucoma, age-related macular degeneration, childhood vision loss, and short-sightedness are highlighted as target study areas.
